BRIDGEBIO PHARMA INC's ticker is and the CUSIP is 10806XAB8. A total of 41 filers reported holding BRIDGEBIO PHARMA INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.5%.
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HIGHBRIDGE CAPITAL MANAGEMENT LLC | 49,655,000 | $82,515,000 | 3.29% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 80,000,000 | $131,952,000 | 2.77% |
| Aequim Alternative Investments LP | 22,000,000 | $36,397,000 | 2.35% |
| WOLVERINE ASSET MANAGEMENT LLC | 66,696,000 | $110,306,000 | 0.93% |
| Polar Asset Management Partners Inc. | 50,000,000 | $82,872,000 | 0.82% |
| Castle Creek Arbitrage, LLC | 6,500,000 | $10,746,000 | 0.62% |
| Soleus Capital Management, L.P. | 1,950,000 | $3,216,000 | 0.58% |
| WESTWOOD HOLDINGS GROUP INC | 16,000,000 | $26,497,000 | 0.27% |
| Nicholas Investment Partners, LP | 2,100,000 | $3,464,000 | 0.24% |
| Magnetar Financial LLC | 14,500,000 | $24,028,000 | 0.23% |